This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Cofoe Medical Technology Co.,Ltd. Announces Final Dividend of A Shares for 2023, Payable on 12 June 2024 CI
Suzhou Neulink Medical Technology Co., Ltd. announced that it has received funding from Redhill Capital, Cofoe Medical Technology Co.,Ltd., and other investors CI
Cofoe Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Cofoe Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on January 26, 2024. CI
Cofoe Medical Technology Co.,Ltd. announces an Equity Buyback for 1,886,792 shares, representing 0.9% for CNY 100 million. CI
Cofoe Medical Technology Co.,Ltd. authorizes a Buyback Plan. CI
Tranche Update on Cofoe Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on December 30, 2022. CI
Cofoe Medical Technology Co.,Ltd.'s equity Buyback announced on December 30, 2022, has closed with 4,202,369 shares, representing 2.06% for CNY 156.32 million. CI
Hunan Cofoe Medical Equipment Co., Ltd. announced that it expects to receive CNY 166.8872 million in funding from Cofoe Medical Technology Co.,Ltd. CI
Cofoe Medical Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Certain A Shares of Cofoe Medical Technology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 26-OCT-2023. CI
Cofoe Medical Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tranche Update on Cofoe Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on December 30, 2022. CI
Cofoe Medical Technology Co.,Ltd. Approves Profit Distribution Plan for 2022, Payable on 25 May 2023 CI
Cofoe Medical Technology Co.,Ltd. Proposes Profit Distribution Plan for 2022 CI
Cofoe Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tranche Update on Cofoe Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on December 30, 2022. CI
Cofoe Medical Technology Co.,Ltd. Approves Board Elections CI
Tranche Update on Cofoe Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on December 30, 2022. CI
Cofoe Medical Technology Co.,Ltd. announces an Equity Buyback for CNY 200 million worth of its shares. CI
Cofoe Medical Technology Co.,Ltd. authorizes a Buyback Plan. CI
Cofoe Medical Technology Co.,Ltd. signed Share Purchase Framework Agreement to acquire Hangzhou Laihe Biotech Co., Ltd. from Ouyang Yun, Hangzhou Jisai Investment Management Partnership Enterprise (Limited Partnership), Ningbo Dongxiaojiang Technology Services Partnership Enterprise (Limited Partnership) and others shareholder for CNY 1000 million. CI
Cofoe Medical Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Certain A Shares of Cofoe Medical Technology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 26-OCT-2022. CI
Cofoe Medical Technology Co.,Ltd.(XSEC:301087) added to S&P Global BMI Index CI
Chart Cofoe Medical Technology Co.,Ltd.
More charts
Cofoe Medical Technology Co Ltd is a China-based company mainly engaged in the research and development, production, sales and service of household medical devices. The Company owns the Cofoe brand. The Company's products include health monitoring, rehabilitation aids, medical care, traditional Chinese medicine physiotherapy, respiratory support and others, such as blood pressure monitors, infrared thermometers, nursing beds, wheelchairs, nebulizers, moxibustion series, health protection supplies, etc. The Company conducts its businesses within the domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. 301087 Stock
  4. News Cofoe Medical Technology Co.,Ltd.
  5. Medical Device Maker Cofoe Medical Frees Up 2 Million Shares for Trading